{"id":307034,"date":"2025-07-31T16:38:19","date_gmt":"2025-07-31T16:38:19","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/307034\/"},"modified":"2025-07-31T16:38:19","modified_gmt":"2025-07-31T16:38:19","slug":"cancer-blood-test-trial-offering-hope-to-dorset-patients","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/307034\/","title":{"rendered":"Cancer blood test trial offering hope to Dorset patients"},"content":{"rendered":"<p>\n  The MODERNISED study, currently running in Dorset, has recruited more than 450 participants as it evaluates a new blood test designed to detect multiple cancers at their earliest stages.\n<\/p>\n<p>\n  Unlike other tests in development, the technology being trialled identifies immune system responses to cancer rather than relying on DNA markers.\n<\/p>\n<p>\n  The test is also being assessed for its ability to pinpoint the type of cancer detected.\n<\/p>\n<p>\n  The study is taking place at five hospitals across the UK, including University Hospitals Dorset and Dorset County Hospital.\n<\/p>\n<p>\n  \u200bIt is led by researchers in Southampton in collaboration with the Southampton Clinical Trials Unit and Proteotype Diagnostics Ltd.\n<\/p>\n<p>\n  The trial is funded by the National Institute for Health and Care Research (NIHR) Invention for Innovation programme and the Office for Life Sciences.\n<\/p>\n<p>\n  <strong>READ:<\/strong> <a href=\"https:\/\/www.dorsetecho.co.uk\/news\/25202309.breakthrough-blood-test-trial-dementia-diagnosis-begins-dorset\/?ref=ial\" target=\"_blank\" rel=\"noopener\">Breakthrough blood test trial for dementia diagnosis begins in Dorset<\/a>\n<\/p>\n<p>\n  <img   alt=\"Ian Robinson taking part in MODERNISED at UHS.\" style=\"width: 100%;\"\/>Ian Robinson taking part in MODERNISED at UHS.\u00a0\n<\/p>\n<p>\n  Ian Robinson, 72, who was diagnosed with colorectal cancer following routine screening, is among those taking part in the study.\n<\/p>\n<p>\n  Mr Robinson said: &#8220;I was sent the NHS bowel cancer screening kit.\n<\/p>\n<p>\n  &#8220;I think I had done four of these, normally with a negative result, but the most recent one indicated that there was a chance of cancer which was confirmed with a colonoscopy.\n<\/p>\n<p>\n  &#8220;There were no symptoms, no pain, nothing, so you would never know until it was much more advanced and therefore much more difficult to treat.&#8221;\n<\/p>\n<p>\n  He said he was pleased to take part in the trial.\n<\/p>\n<p>\n  Mr Robinson said: &#8220;Obviously the team here is helping me, so I\u2019m delighted to participate and hopefully help improve the way things are done.\n<\/p>\n<p>\n  &#8220;My mother died from cancer. I now have children and five grandchildren, so yes, research is absolutely vital.\n<\/p>\n<p>\n  &#8220;The more cancers that can be identified as early as possible, that can benefit future generations, then it\u2019s obviously the right way to go.&#8221;\n<\/p>\n<p>\n  <strong>READ:<\/strong> <a href=\"https:\/\/www.dorsetecho.co.uk\/news\/25247026.dorset-charity-helps-woman-fund-potentially-life-extending-cancer-drug\/?ref=ial\" target=\"_blank\" rel=\"noopener\">Dorset charity helps woman to fund potentially life-extending cancer drug<\/a>\n<\/p>\n<p>\n  <img   alt=\"Victoria Goss, patients,\u201d says Dr Victoria Goss, associate professor and head of Early Diagnosis Research at the Southampton Clinical Trials Unit.\" style=\"width: 100%;\"\/>Victoria Goss, associate professor and head of Early Diagnosis Research at the Southampton Clinical Trials Unit. (Image: UHS) Each year, around 385,000 people in the UK are diagnosed with cancer.\n<\/p>\n<p>\n  Dr Victoria Goss, associate professor and head of early diagnosis research at the Southampton Clinical Trials Unit, said: &#8220;When cancers are diagnosed later, there are often fewer treatment options available to patients.\n<\/p>\n<p>\n  &#8220;Detecting cancer early means that treatment can begin sooner, increasing the chances of successful outcomes for patients.\n<\/p>\n<p>\n  &#8220;Improving early diagnosis is therefore a priority for us as researchers and for the NHS.\n<\/p>\n<p>\n  &#8220;But currently there are only four screening programmes in the UK and screening is only for one cancer at a time, so we are aiming to develop simple tests that can potentially pick up the signs of multiple cancers, giving the best possible chance of early, successful treatment.&#8221;\n<\/p>\n<p>\n  <strong>READ:<\/strong> <a href=\"https:\/\/www.dorsetecho.co.uk\/news\/25308321.walkers-raise-900k-macmillan-cancer-support\/?ref=ial\" target=\"_blank\" rel=\"noopener\">Walkers raise over \u00a3900k for Macmillan Cancer Support<\/a>\n<\/p>\n<p>\n  <img   alt=\"Prof Andy Davies.\" style=\"width: 100%;\"\/>Prof Andy Davies. (Image: UHS) The study is led by Professor Andy Davies, director of the Southampton Cancer Research UK and NIHR Experimental Cancer Medicine Centre.\n<\/p>\n<p>\n  Professor Davies said: &#8220;Most current research into multi-cancer blood tests is focussed on detecting abnormal DNA that has been released into the blood stream by cancer cells.\n<\/p>\n<p>\n  &#8220;But this circulating tumour DNA cannot always be detected in the very early stages of cancer.\n<\/p>\n<p>\n  &#8220;We are instead looking at levels of certain proteins found in blood.\n<\/p>\n<p>\n  &#8220;We know that even in the earliest stages of cancer, the body\u2019s immune response can lead to higher levels of these proteins being released, and we believe these may be a good way to test for early signs of the disease.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"The MODERNISED study, currently running in Dorset, has recruited more than 450 participants as it evaluates a new&hellip;\n","protected":false},"author":2,"featured_media":307035,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[105,4348,16,15],"class_list":{"0":"post-307034","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-health","9":"tag-healthcare","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114948833411900116","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/307034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=307034"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/307034\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/307035"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=307034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=307034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=307034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}